GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Recce Pharmaceuticals Ltd (STU:R9Q) » Definitions » FCF Yield %

Recce Pharmaceuticals (STU:R9Q) FCF Yield % : -133.22 (As of Mar. 30, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Recce Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Recce Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-8.23 Mil, and Market Cap is €5.86 Mil. Therefore, Recce Pharmaceuticals's FCF Yield % for today is -133.22%.

The historical rank and industry rank for Recce Pharmaceuticals's FCF Yield % or its related term are showing as below:

STU:R9Q' s FCF Yield % Range Over the Past 10 Years
Min: -152.96   Med: 0   Max: 0
Current: -133.22


STU:R9Q's FCF Yield % is ranked worse than
87.02% of 1502 companies
in the Biotechnology industry
Industry Median: -14.915 vs STU:R9Q: -133.22

Recce Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.


Recce Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Recce Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recce Pharmaceuticals FCF Yield % Chart

Recce Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -4.42 -5.12 -5.99 -13.14 -11.30

Recce Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.64 -5.21 -12.96 -11.21 -113.22

Competitive Comparison of Recce Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Recce Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recce Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Recce Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Recce Pharmaceuticals's FCF Yield % falls into.


;
;

Recce Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Recce Pharmaceuticals's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-8.113 / 71.803424
=-11.30%

Recce Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-4.199 * 2 / 7.417144
=-113.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Recce Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Recce Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Recce Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Recce Pharmaceuticals Business Description

Traded in Other Exchanges
Address
180 George Street, Level 23, Salesforce Tower, Sydney, NSW, AUS, 2000
Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. The company operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat diseases caused by various bacteria namely Sepsis, Neisseria gonorrhoeaei, Escherichia coli, Mycobacterium abscessus, and others.

Recce Pharmaceuticals Headlines

No Headlines